Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Mary Johansen

3PUBLICATIONS

14CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jan 03, 2025

A trial of radiolabeled antibody yttrium-90-FF-21101 for the treatment of advanced ovarian and other cancers.

Devalingam Mahalingam, Taofeek K Owonikoko, Ebrahim Delpassand

|Mar 07, 2023

A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF-10502-01 for the treatment of advanced solid tumors.

Filip Janku, Milind M Javle, Shiraj Sen

|Aug 21, 2020

Phase I Study of P-cadherin-targeted Radioimmunotherapy with <sup>90</sup>Y-FF-21101 Monoclonal Antibody in Solid Tumors.

Vivek Subbiah, William Erwin, Osama Mawlawi

Pageof 1

Frequent Collaborators

2 joint publications

Vivek Subbiah

2 joint publications

David Wages

1 joint publications

Milind M Javle

1 joint publications

Shubham Pant

1 joint publications

William Erwin

1 joint publications

Catherine Wheeler

1 joint publications

Homer Macapinlac

1 joint publications

David S Hong

1 joint publications

Jason Roszik

1 joint publications

Hirokazu Satoh

Frequent Collaborators

2 joint publications

Vivek Subbiah

2 joint publications

David Wages

1 joint publications

Milind M Javle

1 joint publications

Shubham Pant

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases

Published on : Jan 09, 2019

See more related videos

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases

Published on : Jan 09, 2019

See more related videos